In 1971, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) was founded and received its NCI designation in the same year. Areas of research emphasis include gene therapy, immunotherapy, obesity/energetics, microbiome, genomics, and drug discovery and development.